Pulled lower by UnitedHealth Group’s ( UNH) paring back of its forecasts for 2025—the news has the giant’s shares down ...

The decline is milder than the 23% nosedive UnitedHealth stock took after its first-quarter earnings missed Wall Street estimates. The healthcare bellwether cut its 2025 earnings guidance in light of ...

Humana's stock has shown resilience, boosted by a 5% increase in Medicare Advantage payments. Read my analysis of HUM stock.

UnitedHealth Group is well-positioned with improved guidance for 2025, but faces ongoing challenges. Read why I maintain my ...

UnitedHealth Group Incorporated UNH and Humana Inc. HUM are two of the most prominent players in the U.S. health insurance ...

Humana (HUM) shares ended the last trading session 10.7% higher at $281.95. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...

Guggenheim analyst Jason Cassorla initiated coverage of Humana (HUM) with a Buy rating and $326 price target The firm launched coverage on 11 ...

But Humana Inc.'s stock (HUM) rose more than 11% in Monday's after-hours action, while CVS Health Corp.'s stock (CVS) gained 6.5% and UnitedHealth Group Inc.'s stock (UNH) advanced nearly 6%.

Allow the Sale, Sharing or use of My Personal information for Targeted Advertising If you switch this toggle to “no,” we will not sell or share your personal information with third parties for ...

The bank which administers the Premium Bonds draw has warned of changes to prize fund rates from April 1, 2025 in a blow to investors. National Savings and Investments (NS&I) – is the UK ...

Humana Stock Down 2.4 % Shares of NYSE HUM opened at $263.95 on Monday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a market cap ...